Epstein Secrets

s: malignant vs. "benign." Their classification and effects on cognition. o Movement disorders and their cognitive component: Parkinson's disease, Huntington's disease, ALS. Their neurobiology, natural history, and cognitive profiles. Diagnostic and differential diagnosis issues. o Addictions and substan

as and affective disorders. Their neurobiology, subtypes, natural histories, and cognitive profiles. Diagnostic and differential diagnosis issues. o Neurodevelopmental disorders: dyslexias, non-verbal learning disabilities, memory- based learning disabilities, autism, ADHD, Tourette's syndrome. Their neurobiology,

s: malignant vs. "benign." Their classification and effects on cognition. o Movement disorders and their cognitive component: Parkinson's disease, Huntington's disease, ALS. Their neurobiology, natural history, and cognitive profiles. Diagnostic and differential diagnosis issues. o Addictions and substan

as and affective disorders. Their neurobiology, subtypes, natural histories, and cognitive profiles. Diagnostic and differential diagnosis issues. o Neurodevelopmental disorders: dyslexias, non-verbal learning disabilities, memory- based learning disabilities, autism, ADHD, Tourette's syndrome. Their neurobiology,

s: malignant vs. "benign." Their classification and effects on cognition. o Movement disorders and their cognitive component: Parkinson's disease, Huntington's disease, ALS. Their neurobiology, natural history, and cognitive profiles. Diagnostic and differential diagnosis issues. o Addictions and substan

as and affective disorders. Their neurobiology, subtypes, natural histories, and cognitive profiles. Diagnostic and differential diagnosis issues. o Neurodevelopmental disorders: dyslexias, non-verbal learning disabilities, memory- based learning disabilities, autism, ADHD, Tourette's syndrome. Their neurobiology,